Please use this identifier to cite or link to this item:
Full metadata record
|dc.description.abstract||Curcumin is a yellow-orange powder derived from the rhizome of Curcuma longa Linn. In traditional medicine, curcumin has been used to treat several diseases. Much evidence has shown curcumin's anti-ulcer, anti-cancer, anti-hepatotoxic, anti-viral, accelerated wound healing, cardioprotective, hypoglycemic and anti-inflammatory properties. Recently, several in vitro and in vivo studies have shown that curcumin has various properties which help prevent the pathogenesis of Alzheimer's disease (AD). These effects include anti-amyloid, anti-inflammation, antioxidant, anti-apoptotic and cholesterol lowering properties. These findings suggest the possible benefits of curcumin in AD therapy. In this review, the pathogenesis of, as well as current therapeutic strategies for, AD are presented and evidence of the role of curcumin in preventing the pathogenetic cascades which underlie AD are discussed. Copyright © 2009 by New Century Health Publishers, LLC.||en_US|
|dc.title||Roles of curcumin in preventing pathogenesis of Alzheimer's disease||en_US|
|article.title.sourcetitle||Current Topics in Nutraceutical Research||en_US|
|article.stream.affiliations||Faculty of Medicine, Thammasat University||en_US|
|article.stream.affiliations||Chiang Mai University||en_US|
|Appears in Collections:||CMUL: Journal Articles|
Files in This Item:
There are no files associated with this item.
Items in CMUIR are protected by copyright, with all rights reserved, unless otherwise indicated.